*ST生物
(000504)
| 流通市值：22.55亿 | | | 总市值：23.96亿 |
| 流通股本：3.11亿 | | | 总股本：3.30亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 141,405,896.11 | 207,363,146.93 | 214,737,973.7 | 204,539,871.63 |
| 应收票据及应收账款 | 136,633,751.11 | 139,581,939.21 | 129,217,053.18 | 124,635,074.26 |
| 其中：应收票据 | 12,000,000 | - | - | - |
| 应收账款 | 124,633,751.11 | 139,581,939.21 | 129,217,053.18 | 124,635,074.26 |
| 预付款项 | 7,338,803.89 | 3,885,112.92 | 8,573,224.1 | 3,385,717.94 |
| 其他应收款合计 | 4,895,395.88 | 4,393,557.13 | 11,822,002.54 | 10,873,806.85 |
| 存货 | 21,886,655.45 | 34,058,655.58 | 19,581,307.29 | 18,443,831.52 |
| 其他流动资产 | 47,262,965.06 | 12,014,008.66 | 8,417,922.01 | 7,886,082.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 389,870,377.5 | 401,904,309.43 | 492,882,061.82 | 472,210,483.31 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 2,692,448.15 |
| 其他非流动金融资产 | 100,000,000 | 100,000,000 | - | - |
| 固定资产 | 12,900,399.33 | 13,494,475.46 | 13,505,078.63 | 13,966,797.06 |
| 使用权资产 | 11,776,831.18 | 12,560,458.6 | 11,535,254.09 | 11,830,998.76 |
| 无形资产 | 2,944,648.56 | 1,857,086.22 | 398,439.72 | 412,565.49 |
| 商誉 | 1,983,226.77 | 1,983,226.77 | 1,983,226.77 | 1,983,226.77 |
| 长期待摊费用 | 80,421,824.77 | 73,749,023.1 | 72,334,986.34 | 75,018,642.11 |
| 递延所得税资产 | 1,915,770.17 | 1,915,770.17 | 1,410,011.39 | 1,410,011.39 |
| 其他非流动资产 | 101,784.06 | 705,468.22 | 37,970.13 | 37,970.13 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 212,044,484.84 | 206,265,508.54 | 101,204,967.07 | 107,352,659.86 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 601,914,862.34 | 608,169,817.97 | 594,087,028.89 | 579,563,143.17 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 86,624,689.73 | 84,466,271.24 | 70,562,975.46 | 80,413,693.87 |
| 应付账款 | 86,624,689.73 | 84,466,271.24 | 70,562,975.46 | 80,413,693.87 |
| 合同负债 | 192,208,678.95 | 185,176,948.66 | 174,526,437.7 | 169,508,453.65 |
| 应付职工薪酬 | 3,567,083.91 | 5,896,443.57 | 3,260,040.23 | 3,151,222.14 |
| 应交税费 | 1,106,342.3 | 4,437,781.78 | 2,239,258.1 | 1,235,935.38 |
| 其他应付款合计 | 4,943,451.99 | 7,005,666.49 | 4,277,242.43 | 4,381,493.73 |
| 应付股利 | 931,102.81 | 931,102.81 | 931,102.81 | 931,102.81 |
| 一年内到期的非流动负债 | 1,877,474.76 | 4,608,415.22 | 1,494,132.48 | 3,326,360.43 |
| 其他流动负债 | 14,297,501.52 | 13,879,559.74 | 12,752,434.73 | 12,520,495.61 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 304,625,223.16 | 305,471,086.7 | 269,112,521.13 | 274,537,654.81 |
| 非流动负债: | | | | |
| 长期借款 | 8,500,000 | 9,000,000 | 9,000,000 | - |
| 租赁负债 | 12,366,124.74 | 10,449,883.62 | 13,920,288.64 | 10,897,797.21 |
| 递延收益 | 1,056,313.92 | 1,099,026.92 | 681,732 | 1,137,245 |
| 递延所得税负债 | 124,323.19 | 151,713.49 | 168,396.3 | 195,750.27 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 22,046,761.85 | 20,700,624.03 | 23,770,416.94 | 12,230,792.48 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 326,671,985.01 | 326,171,710.73 | 292,882,938.07 | 286,768,447.29 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,023,098 | 330,023,098 | 330,023,098 | 330,023,098 |
| 资本公积 | 423,472,870.01 | 423,472,870.01 | 430,981,998.93 | 423,472,870.01 |
| 盈余公积 | 34,545,734.18 | 34,545,734.18 | 34,545,734.18 | 34,545,734.18 |
| 未分配利润 | -553,165,154.43 | -550,946,522.17 | -546,903,703.31 | -539,493,334.1 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 234,876,547.76 | 237,095,180.02 | 248,647,127.8 | 248,548,368.09 |
| 少数股东权益 | 40,366,329.57 | 44,902,927.22 | 52,556,963.02 | 44,246,327.79 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 275,242,877.33 | 281,998,107.24 | 301,204,090.82 | 292,794,695.88 |
| 负债和股东权益合计 | 601,914,862.34 | 608,169,817.97 | 594,087,028.89 | 579,563,143.17 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |